Religare gets shareholders' nod to invest Rs 500cr in its arm

Image
Press Trust of India Mumbai
Last Updated : Sep 11 2017 | 10:02 PM IST
Religare Enterprises shareholders have approved a proposal to invest up to Rs 500 crore in its arm Religare Capital Markets for repaying debt related to Mauritius business, and capital needs of India business.
The shareholders have given their approval to an ordinary resolution through postal ballot, the company said today in a regulatory filing.
As per the voting result, 55.633 per cent shareholders voted in favour of the proposal, while the remaining 44.367 per cent were against it.
The voting result also showed that 99.95 per cent of total votes casted by public institutional shareholders were against the resolution. Promoters did not participate in voting.
However, 99.03 per cent of the public non-institution shareholders who participated in the voting were in favour of the proposal.
The voting was closed on September 9.
In the postal ballot notice issued in July, Religare Enterprises had said that it proposes to make further capital investment of up to Rs 500 crore in Religare Capital Markets (RCML).
Religare Enterprises will use part of sale proceed from divestment of its health insurance business to make investment in RCML.
It further said that RCML subsidiary Religare Capital Market International, Mauritius Ltd (RCMIML) had availed 'stand-by letter of credit facility' (SBLC) of USD 72.5 million from Axis Bank in 2014.
The Mauritius arm had drawn down USD 70 million from Axis Bank, Hongkong against SBLC facility.
"The SBLC facility is falling due for repayment. Since RCML and RCMIML are in losses and have negative cash flows, they need support from the holding company, which is Religare Enterprises Ltd," the July 26 notice said.
To repay the SBLC facility at RCMIML level, Religare Enterprises said it will capitalise RCML, which in turn further capitalise RCMIML to repay the Axis Bank loan.
RCML also need additional fund for its India business, the notice said, explaining the rationale behind infusion of up to Rs 500 crore.
Shares of Religare Enterprises closed at Rs 42.40, up 4.95 per cent on BSE.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 11 2017 | 10:02 PM IST

Next Story